DDW Cancer Summit: Master biomarker-driven approaches

Biomarkers concept

The DDW Turning Science into Business Summit, ‘Cancer research opportunities and advances’ will take place online on 16 November at 7AM PDT / 10AM EDT / 3PM GMT / 4PM CET and will be available on-demand after that date.

The free summit, sponsored by Taconic Biosciences, will offer expert thought leadership on cancer research, precision medicine and immunotherapy.

Raffi Tonikian
Raffi Tonikian

DDW is delighted to confirm that the event will feature a talk by Dr Raffi Tonikian, Director of Translational Biomarkers at AbCellera, sharing his broad expertise in autoimmunity and oncology.

Dr Tonikian will speak on ‘Early integration of biomarker-driven approaches for bispecific development’, focusing on how to leverage biomarker information early to streamline the path to the clinic.

What you will learn:

How to leverage biomarker information early to streamline the path to the clinic by:

  • Making biomarker-driven decisions for in vitro functional screening
  • Fine-tuning function by optimizing multispecific formats
  • Using pre-clinical biomarkers with clinical relevance

Register for free to secure your place or to receive your exclusive download link after the event.

Related Articles

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free